UK researchers identify level of antibodies needed to prevent symptomatic Covid-19 June 24, 2021 Scientists at the University of Oxford said the results of their research could help speed up new vaccine development. Oxford-based medical researchers have today released a new study indentifying the level of antibodies required to prevent symptomatic Covid – referred to as the “correlates of protection”. Their findings could serve as a huge breakthrough in [...]
US health agency says ‘likely association’ between heart inflammation and Covid vaccine June 23, 2021 The US national health agency said there was a “likely association” between a rare inflammatory heart condition and the Covid vaccine in teenagers and young adults. The Centers for Disease Control and Prevention (CDC) said there was “a “likely association of myocarditis with mRNA vaccination” in young people, mostly after they’ve received their second vaccine. [...]
London vaccine race: Mass events send new boroughs to the front June 23, 2021 Haringey has shot to the front of the vaccine race after a mass vaccination event took place at Tottenham Hotspur stadium at the weekend. Almost 4,200 Pfizer vaccinations were received at the stadium on Sunday, according to the latest NHS vaccine data. Haringey, the borough that hosted the stadium event, administered 2,445 first doses of [...]
Three in five adults in the UK have now received two vaccine doses June 23, 2021 More than 60 per cent of adults in the UK have now received two doses of the Covid vaccine, as the rollout continues with pace. The milestone follows last week’s extension of the vaccine invite to all over-18s in the UK. 75m doses of the Covid vaccines have now been administered in the UK, the [...]
41 cases of ‘Delta plus’ Covid strain found in UK June 23, 2021 41 cases of a mutation of the Delta variant of coronavirus, being labelled “Delta plus”, have been found in England. Public Health England (PHE) confirmed it is monitoring 41 cases of Delta-AY.1 – a mutation of the Delta “variant of concern” that originated in India. The first cases of the Delta strain in England were [...]
BioNTech considers possible dividend next year June 22, 2021 The German biotech, which developed its lucrative vaccine with Pfizer, said it was looking into a potential dividend next year. BioNTech, which shares gross profits on the Covid vaccine with Pfizer on a 50:50 basis, said it would consider paying out a dividend in 2022, but that its focus for this year was spending on [...]
The vaccine race is on: London borough winners and losers June 21, 2021 Richmond currently wears the crown as the London borough that has vaccinated the highest proportion of its adult population, according to the latest NHS data. The south west London borough has vaccinated 132,627 of its residents with a first dose – 85 per cent of its 156,399 population over the age of 16. Richmond also [...]
Moderna set to expand Covid-19 vaccine production June 21, 2021 Moderna Inc is adding two new production lines at its coronavirus vaccine manufacturing plant, as it prepares to ramp up booster shot production. The US biotech firm’s plans will increase overall production capacity at its Massachusetts plant by 50 per cent, the Wall Street Journal first reported. The move indicates that Moderna expects the market [...]
Delta variant now makes up 99 per cent of new Covid cases in UK June 18, 2021 The Delta variant now accounts for 99 per cent of new Covid-19 cases in the UK, according to the latest Public Health England data. In the week to June 14, Britain reported another steep rise in new cases of the Delta variant, which was first identified in India. The latest PHE data showed the variant [...]
CureVac shares plunge after Covid vaccine falls short in clinical trial June 17, 2021 The German biotech lost more than half its value after a preliminary analysis of late-stage trials found its Covid-19 vaccine was only 47 per cent effective. CureVac’s disappointing mRNA vaccine trial results call into question its future contribution to the global vaccination effort. The interim analysis of the jab’s trials found that it was one [...]